90 results about "Pathogen reduction" patented technology

While clean, disinfected hands are widely recognized as a principle means for controlling the spread of infections, disease, and similar health problems to both self and others, the prompt and repeated application of such materials as soap and water or waterless gels is necessary to maintain sanitary hands. So well recognized is this fact that many professional and governmental guidelines backed by regulations have been drawn to enforce compliance. This invention relates to compliance monitoring of hand sanitizing fluids and gels used to reduce the hand-borne transmission of pathogens. Disclosed is a simple, low-cost method of which a key aspect is the employment of a wristband dispenser with plural individual applications of hand sanitizing fluid in a convenient dispensing form. Inclusion of a use activated timing device provides a means of monitoring an individual's elapsed time since last use.

A mixing system, apparatus and / or method. Pathogen reduction of and / or mixing storage solutions into blood or blood components are useful purposes for these. Squeezing or clapping devices may be used to activate the mixing process, as may rotational devices or laterally movable, rotational and / or orbital devices. Constriction elements may also be used to create useful vortex mixing actions. Photoradiation may be provided while the components continue to be mixed together for pathogen reduction of blood or blood components.

A method and apparatus for implementing pathogen reduction within a poultry processing or food processing plant that uses water that has been treated with chloramines at an advantageous dosage before being introduced to the production process at processing steps. The water treated with chloramines may be from a fresh water source or reclaimed water from the processing plant. The reintroduction of the treated reclaimed water advantageously causes a dramatic reduction in the levels of microorganisms associated with poultry processing, while substantially conserving water use.

An apparatus for the fixed-film anaerobic digestion of flushed livestock manure includes an enclosed digester tank (fixed or flexible roof), internal media for biofilm development, a biogas collection and flare system, various pumps, and hydraulic control systems. The preferred media has substantially vertically-oriented, uninterrupted channels to promote enhanced bacterial attachment and biofilm development. The immobilization of microbial biomass within the reactor as a biofilm allows effective treatment of the wastewater at ambient and higher temperatures, as well as reasonable hydraulic retention times. The composition and concentration of bacterial groups in the biofilm developed on the media in the fixed-film digester result in a significantly enhanced anaerobic degradation process. This novel fixed-film digester design expands the potential application of anaerobic digestion to dilute livestock waste with significant levels of suspended solids. This holistic manure treatment system not only stabilizes the wastewater but also produces energy (biogas), controls odors, reduces pathogens, minimizes environmental impact from waste emissions, and maximizes fertilizer and water recovery for reuse.

The invention relates to an apparatus system and methods for treatment of virus-infected or pathogen-loaded human blood components separated from normal components comprising a separation apparatus and treatment apparatus system that inactivate pathogens in an extracorporeal body fluid system.

The invention relates to an apparatus system and methods for treatment of virus-infected or pathogen-loaded human blood components separated from normal components comprising a separation apparatus and treatment apparatus system that inactivate pathogens in an extracorporeal blood system.

The systems and methods for pathogen reduction in donor blood operates by exposure of blood to UVC irradiation. Unwanted wavelengths of light, mostly in the infrared spectra, may be precluded from reaching blood by providing a layer of IR-absorbing fluid positioned between blood and the source of UV irradiation, whereby minimizing energy absorption and heating of blood. Some embodiments further disclose a system configured to utilize the same IR-absorbing fluid to actively cool blood by flowing along the flow path thereof.

Carbon dioxide is dissolved in perishable liquids loaded into pressure vessels that are provided with low carbon dioxide head pressure so as to improve product shelf life, thereby providing options for more economical shipment, as by rail and ocean vessels and for extended transport by truck and to facilitate extended storage of perishable products and to avoid the necessity of multiple treatments for pathogen reduction.

This invention relates to devices and a method promoting the convenient use of hand sterilizing fluids and gels applied to reduce the hand-borne transmission of pathogens. While clean, disinfected hands are widely recognized as a principle means for controlling the spread of infections, disease, and similar health problems to both self and others, the prompt and repeated application of such materials as soap and water or waterless alcohol gels is necessary for maintaining a sanitary hand condition. This is particularly true for nurses, health care providers, veterinarians, elementary teachers, food handlers and others where rapid and continuous movement between patients, clients and tasks provides optimum conditions for cross-contamination. This invention of a convenient, wrist-mounted dispenser of hand sterilizing fluids in a blister package format advances the use of such materials to effectively control the spread of hand-borne pathogens.

A process and apparatus for the treatment of septage, particularly grease trap waste, is disclosed. The inventive process will convert the septage into Biosolids (sludge) and water dischargeable to the environment. The treated septage achieves pathogen reduction, and reduced vector attraction. Treatment of septage by pasteurization causes the destruction of harmful pathogens. Pasteurization of septage having high water content provides for even temperature elevation and distribution of heat within the thermal mass of the septage allowing for consistent pathogen destruction. An alkaline compound is utilized to form a filter cake from the solids fraction of the pasteurized septage preventing vector attraction, while producing a beneficial bio-solid. The liquid fraction of the septage is treated by biological process allowing for its discharge into the environment.

An water providing apparatus includes a input portion for receiving untreated water, a treatment portion for treating and outputting treated water having a UV treatment module for reducing pathogens, a filtering mechanism for reducing physical and chemical impurities, a UV analysis module for determining levels of the impurities in the untreated water and for determining levels of impurities in the treated water, a processing unit for determining whether the levels of impurities in the treated water exceed a threshold, a reporting module for outputting the levels of the impurities in the untreated and treated water to a remote monitoring service, and a water output portion for providing the treated water if safe, and for inhibiting output of the treated water if unsafe.

The invention relates to an apparatus system and methods for treatment of virus-infected or pathogen-loaded human blood components separated from normal components comprising a separation apparatus and treatment apparatus system that inactivate pathogens in an extracorporeal body fluid system.

A method and apparatus for implementing pathogen reduction within a poultry processing or food processing plant that uses water that has been treated with chloramines at an advantageous dosagebefore being introduced to the production process at processing steps. The water treated with chloramines may be from a fresh water source or reclaimed water from the processing plant. The reintroduction of the treated reclaimed water advantageously causes a dramatic reduction in the levels of microorganisms associated with poultry processing, while substantially conserving water use.

An isolating-disinfecting apparatus for the infections diseases in respiratory tract is composed of an enclosed isolating cover with operating windows and an exhalated air collecting tube, and a disinfecting machine with an air inlet connected to said exhalated air collecting tube via a flexible tube. Its advantage is high effect.

The invention relates to an apparatus system and methods for treatment of virus-infected or pathogen-loaded human blood components separated from normal components comprising a separation apparatus and treatment apparatus system that inactivate pathogens in an extracorporeal body fluid system.

A suction apparatus for aspirating a fluid from a human or animal body by means of negative pressure comprises a drainage connection for a drainage line in order to remove the fluid from the body. A vacuum source generates a negative pressure at the drainage connection. A fluid connection container collects the sucked-up fluid. The drainage line can be flushed with air by an auxiliary connection and an auxiliary line connected to the latter. In order to reduce the entraining of pathogens, a sterilizing cell is provided. The supplied air is treated in the latter in such a manner that pathogens contained in said air are modified and thereby rendered harmless.

An apparatus, method and system is provided for treating sewage sludge by dewatering the sewage sludge, heating the sewage sludge being treated to destroy pathogens, and then reducing volatile solids in the sewage sludge being treated through biochemical decomposition to produce a treated biosolids product that meets government regulations for pathogen reduction and vector attraction reduction.

This invention provides methods for treating cellular blood components and other cells containing mitochondria to improve vital qualities of the cells by contacting the cells with a mitochondrial enhancer to the cells. Mitochondrial enhancers prevent damage to and rejuvenate mitochondria and cells containing mitochondria. Mitochondrial enhancers include alloxazines and related compounds, such as riboflavin. Cells are optionally treated with photoradiation to reduce pathogens with may be present, before, after, and / or during treatment with mitochondrial enhancer. Treating with mitochondrial enhancer enables utilization of higher photoradiation energies, which achieves better pathogen reduction. When platelets are treated with mitochondrial enhancer, treated platelets may be stored for longer times than untreated platelets before they are administered to patients.

A reusable two-way respirator mask comprising a filter cover, a filter base, a facepiece, and a filter adapted to remove airborne pathogens. The facepiece is configured to interface with the face of the user and deform under moderate pressure to create a substantially airtight seal with the user's face. The filter cover and filter base a removably coupled such that the user may easily replace the filter by decoupling the filter cover and filter base. Both inhalation and exhalation pass through the filter, reducing the user's inhalation of pathogens and reducing the spread of pathogens from the user to others. The reusable two-way respirator mask is constructed of head resistant materials, suitable for repeated disinfecting.

An apparatus and a method for treating a composition containing toxic materials or biosolids, wherein the apparatus has a hydraulically sealable top that can be opened to allow loading of the composition or closed to seal the apparatus. The apparatus also includes a reagent injection system for injecting a reagent into the apparatus, a mixing device for mixing the composition with the reagent, a heater system for heating the composition, or the mixture of the composition and the reagent, an internal vapor recovery system for recovering gases, vapors, and odors from the toxic materials or biosolids, or from the reagents, a reagent recovery system for recovering the reagent after it has been mixed with the composition, a discharge mechanism for discharging the treated composition, and a control panel comprising temperature and pressure measurements.

Provided is a method and an apparatus for indicating minimum exposure of a surface to UVC light emitted by a source during a decontamination process to achieve a desired level of pathogen reduction. The apparatus includes a photochromic material to be applied to, or applied adjacent to the surface. The photochromic material is to exhibit a visible response to receiving the minimum exposure to the UVC light, and exhibit the visible response to a lesser extent after the photochromic material ceases to be exposed to the UVC light emitted by the source. A protective layer of material that is substantially transparent to the UVC light emitted by the source is positioned over the photochromic material to be disposed between the source and the photochromic material during the decontamination process.

Provided is a method and an apparatus for indicating minimum exposure of a surface to UVC light emitted by a source during a decontamination process to achieve a desired level of pathogen reduction. The apparatus includes a photochromic material to be applied to, or applied adjacent to the surface. The photochromic material is to exhibit a visible response to receiving the minimum exposure to the UVC light, and exhibit the visible response to a lesser extent after the photochromic material ceases to be exposed to the UVC light emitted by the source. A protective layer of material that is substantially transparent to the UVC light emitted by the source is positioned over the photochromic material to be disposed between the source and the photochromic material during the decontamination process.

A method for reducing hemolysis and microparticle formation during storage of pathogen reduced blood. Oxygen reduced blood compositions comprising SAGM and riboflavin having reduced hemolysis. Oxygen reduced blood compositions comprising SAGM and riboflavin having reduced microparticles. Oxygen and pathogen reduced blood compositions comprising CPAD and riboflavin having reduced hemolysis. Oxygen and pathogen reduced blood compositions comprising SAGM and riboflavin having reduced microparticles.

The present invention provides a pharmaceutical composition comprising a chemical compound or a herb extract or the combination having at least one of the activities of antiviral, antibacterial, antifungal, anti-inflammatory, anti-allergy, anti-cancer, promoting membrane healing or immunomodulating, for the treatment and prevention of a disease of a mammal. The present invention also provides a system for delivering the composition to the hard-to-reach sinuses of a mammal to reduce the load of the pathogen, to reduce the amount of inflammatory mediators, to heal pathological changes, and collectively to treat a disease of a mammal, such as allergic fungal rhinosinusitis. The invented method of treating a human disease reduces infectious and inflammatory agents without causing antibiotic resistance or adverse event. The present invention additionally provides a kit for collecting the nasal wash specimen to analyze how much drug is administered into sinonasal cavities or to determine the load of microbes in rhino-sinuses.

A method for reducing hemolysis and microparticle formation during storage of pathogen reduced blood. Oxygen reduced blood compositions comprising SAGM and riboflavin having reduced hemolysis. Oxygen reduced blood compositions comprising SAGM and riboflavin having reduced microparticles. Oxygen and pathogen reduced blood compositions comprising CPAD and riboflavin having reduced hemolysis. Oxygen and pathogen reduced blood compositions comprising SAGM and riboflavin having reduced microparticles.

An apparatus and a method for treating a composition containing toxic materials or biosolids, wherein the apparatus has a hydraulically sealable top that can be opened to allow loading of the composition or closed to substantially seal the apparatus. The apparatus also includes a reagent injection system for injecting a reagent into the apparatus, a mixing device for mixing the composition with the reagent, a heater system for heating the composition, or the mixture of the composition and the reagent, an internal vapor recovery system for recovering gases, vapors, and odors from the toxic materials or biosolids, or from the reagents, a reagent recovery system for recovering the reagent after it has been mixed with the composition, a discharge mechanism for discharging the treated composition, and a control panel comprising temperature and pressure measurements.